More From Forbes
Is Philip Morris Stock A Better Pick Over Union Pacific?","scope":{"topStory":{"index":1,"title":"Is Philip Morris Stock A Better Pick Over Union Pacific?","image":"https://specials-images.forbesimg.com/imageserve/6539e7eb298eaf24a251b656/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"May 22, 2024","hourMinute":"09:30","amPm":"am","isEDT":true,"unformattedDate":1716384621000},"uri":"https://www.forbes.com/sites/greatspeculations/2024/05/22/is-philip-morris-stock-a-better-pick-over-union-pacific/"}},"id":"5idlo8nb5i6c00"},{"textContent":"
Should You Pick Riot Platforms Stock After An 18% Rise In A Week?","scope":{"topStory":{"index":2,"title":"Should You Pick Riot Platforms Stock After An 18% Rise In A Week?","image":"https://specials-images.forbesimg.com/imageserve/664d74851207f47202285d08/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"May 22, 2024","hourMinute":"08:45","amPm":"am","isEDT":true,"unformattedDate":1716381914000},"uri":"https://www.forbes.com/sites/greatspeculations/2024/05/22/should-you-pick-riot-platforms-stock-after-an-18-rise-in-a-week/"}},"id":"86n1l9dpab4800"},{"textContent":"
Biden Tariffs Revive The China Trade War But Trump’s Stance Is Riskier","scope":{"topStory":{"index":3,"title":"Biden Tariffs Revive The China Trade War But Trump’s Stance Is Riskier","image":"https://specials-images.forbesimg.com/imageserve/664d170dd8cbff2b4b926506/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"May 22, 2024","hourMinute":"08:02","amPm":"am","isEDT":true,"unformattedDate":1716379342032},"uri":"https://www.forbes.com/sites/nicksargen/2024/05/22/biden-tariffs-revive-the-china-trade-war-but-trumps-stance-is-riskier/"}},"id":"1fp48mppo3kc00"},{"textContent":"
Up 165% This Year Will Dyne Therapeutics Continue Its Stellar Run?","scope":{"topStory":{"index":4,"title":"Up 165% This Year Will Dyne Therapeutics Continue Its Stellar Run?","image":"https://specials-images.forbesimg.com/imageserve/664d73aa1207f47202285d06/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"May 22, 2024","hourMinute":"08:00","amPm":"am","isEDT":true,"unformattedDate":1716379218000},"uri":"https://www.forbes.com/sites/greatspeculations/2024/05/22/up-165-this-year-will-dyne-therapeutics-continue-its-stellar-run/"}},"id":"c3gcn3ia2p0g00"},{"textContent":"
Can Nvidia Beat The Target?","scope":{"topStory":{"index":5,"title":"Can Nvidia Beat The Target?","image":"https://specials-images.forbesimg.com/imageserve/65d5f3d59190aeac747ec8aa/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"May 22, 2024","hourMinute":"07:34","amPm":"am","isEDT":true,"unformattedDate":1716377640813},"uri":"https://www.forbes.com/sites/jjkinahan/2024/05/22/can-nvidia-beat-the-target/"}},"id":"67521j6b8nko00"},{"textContent":"
Gaining 16% This Year, Will Ralph Lauren Stock Rally Further After Q4 Results?","scope":{"topStory":{"index":6,"title":"Gaining 16% This Year, Will Ralph Lauren Stock Rally Further After Q4 Results?","image":"https://specials-images.forbesimg.com/imageserve/664d726ed80a86a393898260/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"May 22, 2024","hourMinute":"07:15","amPm":"am","isEDT":true,"unformattedDate":1716376530000},"uri":"https://www.forbes.com/sites/greatspeculations/2024/05/22/gaining-16-this-year-will-ralph-lauren-stock-rally-further-after-q4-results/"}},"id":"emlqfp65chbc00"},{"textContent":"
U.S. Bancorp Stock Is Trailing S&P500 By 17% YTD, What’s Next?","scope":{"topStory":{"index":7,"title":"U.S. Bancorp Stock Is Trailing S&P500 By 17% YTD, What’s Next?","image":"https://specials-images.forbesimg.com/imageserve/664d71ffccbf3ff60fde9780/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"May 22, 2024","hourMinute":"06:30","amPm":"am","isEDT":true,"unformattedDate":1716373844000},"uri":"https://www.forbes.com/sites/greatspeculations/2024/05/22/us-bancorp-stock-is-trailing-sp500-by-17-ytd-whats-next/"}},"id":"cj5dh8gn75jc00"},{"textContent":"
What Drove A Nearly 2x Rise In Boston Scientific’s Profits?","scope":{"topStory":{"index":8,"title":"What Drove A Nearly 2x Rise In Boston Scientific’s Profits?","image":"https://specials-images.forbesimg.com/imageserve/60cc466796cf2e57140ee510/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"May 22, 2024","hourMinute":"05:45","amPm":"am","isEDT":true,"unformattedDate":1716371144000},"uri":"https://www.forbes.com/sites/greatspeculations/2024/05/22/what-drove-a-nearly-2x-rise-in-boston-scientifics-profits/"}},"id":"b1fd7qc3kk8g00"}],"breakpoints":[{"breakpoint":"@media all and (max-width: 767px)","config":{"enabled":false}},{"breakpoint":"@media all and (max-width: 768px)","config":{"inView":2,"slidesToScroll":1}},{"breakpoint":"@media all and (min-width: 1681px)","config":{"inView":6}}]};